Axim Biotechnologies, Inc. (AXIM): Operating Cash Flow
Not updated since 2023-12-31. No annual report in US GAAP has been filed since. Companies that switch to IFRS reporting, as many foreign filers do, or stop filing are not updated here.
-$1.03M
Year ended 2023-12-31
| Period ended | Operating Cash Flow | Change YoY | Source filing |
|---|---|---|---|
| 2023-12-31 | -$1.03M | n/m | 2024-04-16, From 2023-01-01 |
| 2022-12-31 | -$2.04M | n/m | 2024-04-16, From 2022-01-01 |
| 2021-12-31 | -$2.49M | n/m | 2023-04-17, From 2021-01-01 |
| 2020-12-31 | -$3.22M | n/m | 2022-04-19, From 2020-01-01 |
| 2019-12-31 | -$5.04M | n/a | 2021-04-26, From 2019-01-01 |
| No annual figure between 2016-12-31 and 2019-12-31. | |||
| 2016-12-31 | -$1.29M | n/m | 2017-09-14, From 2016-01-01 |
| 2015-12-31 | -$1.54M | n/m | 2017-09-14, From 2015-01-01 |
| 2014-12-31 | -$339.0K | n/m | 2016-04-18, From 2014-01-01 |
| 2013-12-31 | -$33.0K | n/m | 2015-04-14, From 2013-01-01 |
| 2012-12-31 | $21.1K | +422.7% | 2013-04-15, From 2012-01-01 |
| 2011-12-31 | $4.0K | n/a | 2013-04-15, From 2011-01-01 |